The UK charity for Waldenstrom’s macroglobulinaemia – a rare type of blood cancer

Support Line: 0300 373 8500

Showing only trials that are North West England

Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies (ELM-1)

Understanding the best doses for Odronextamb in patients with a type of protein on their B-cells

Expected to end: 30/09/2025

The UK charity for Waldenstrom’s Macroglobulinaemia

WMUK, Foden House, 47 London Road,
Alderley Edge, Cheshire, SK9 7JT

Registered as a charity in England and Wales (1187121).

A company limited by guarantee in England and Wales (12358324).

Support Line: 0300 373 8500

General enquiries: 0300 303 5870